Medical devices, healthcare technology and the business of care
510(k) clearance · K261886

VIVO (9002)

Catheter Precision, Inc. · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONK261886

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision for VIVO (9002), submitted by Catheter Precision, Inc. of Fort Mill, South Carolina, under 510(k) number K261886. The application was received on 06/05/2026 and decided on 10/30/2026. The device falls under regulation 870.1425 with classification product code DQK, device classification name "Computer, Diagnostic, Programmable," and the cardiovascular medical specialty and review panel.

A SESE decision means the FDA cleared the submission as substantially equivalent to a legally marketed predicate device; it is not a premarket approval. The public record identifies the applicant contact as Darci Diage and notes the summary type as Special, with no third-party review, no combination product designation, and no authorized predetermined change control plan. The record does not describe the specific components, software changes, or indications for use, so the scope of what was cleared remains unknown from this page.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 30, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261886
Regulatory pathway
510(k) premarket notification
Product code
DQK
Decision code
SESE
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Computer, Diagnostic, Programmable.

Product code
DQK
FDA device class
2

FDA decision timeline

  1. K261886 received

    Application receipt date recorded by FDA.

  2. K261886 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DQK

Product / regulatory recordCompanyPathwayDecision dateSource
Merge Healthcare Incorporated510(k) clearanceNov 5, 2026FDA
PulseAI, Ltd.510(k) clearanceOct 27, 2026FDA
Rhythm AI, Ltd.510(k) clearanceOct 23, 2026FDA
Centerline Biomedical510(k) clearanceOct 1, 2026FDA
Wellysis Corp.510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Catheter Precision, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Fort Mill, SC

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records